Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Image of text that reads "Breaking News" over lymphoma cells.

FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma

May 31, 2024

young girl with blanket

Subaru Partners With The Leukemia & Lymphoma Society For Ninth Year Supporting Patients Facing Cancer

May 31, 2024

An image depicting tablets and laptops with text that reads news.

Breaking Data Presented at ASCO 2024 Showcase Breadth of The Leukemia & Lymphoma Society Therapy Acceleration Program Impact on Key Blood Cancer Research

May 30, 2024

Image of text that reads "Breaking News" over myeloma cells.

FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients

April 16, 2024

cyclists on bikes

Cyclists Take On America’s Most Beautiful Bike Ride In Support Of Blood Cancer Patients

April 3, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Expands Use of Leukemia Treatment to Include Children

March 18, 2024

A zoomed in image of a liquid being dropped into an object for testing

FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma

March 15, 2024

An image with text that reads Breaking News over an image of lymphoma cells.

FDA Approves First Ever BTK Inhibitor to Treat Lymphoma Subtype

March 14, 2024

Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night

March 12, 2024

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.